Steve Hobbs

2.1k total citations
44 papers, 1.6k citations indexed

About

Steve Hobbs is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Steve Hobbs has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Steve Hobbs's work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Steve Hobbs is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Steve Hobbs collaborates with scholars based in United Kingdom, United States and Canada. Steve Hobbs's co-authors include George Janossy, Paul Workman, David M. Davies, May CI van Schalkwyk, S. Burbridge, John Maher, Sjoukje J. C. van der Stegen, Scott Wilkie, Carol Box and Suzanne A. Eccles and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Steve Hobbs

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Hobbs United Kingdom 21 623 564 447 256 246 44 1.6k
M.J. O’Hare United Kingdom 28 1.2k 2.0× 512 0.9× 203 0.5× 163 0.6× 241 1.0× 62 2.5k
Yoshiyuki Takahara Japan 17 815 1.3× 679 1.2× 961 2.1× 252 1.0× 218 0.9× 28 2.4k
C. Khanna United States 21 790 1.3× 516 0.9× 234 0.5× 100 0.4× 396 1.6× 32 2.0k
Alain C. Tissot Switzerland 14 617 1.0× 344 0.6× 1.0k 2.3× 328 1.3× 89 0.4× 23 2.2k
Carlo Ramoni Italy 28 1.1k 1.8× 499 0.9× 1.1k 2.5× 244 1.0× 77 0.3× 44 2.5k
Takushi Tadakuma Japan 26 828 1.3× 261 0.5× 815 1.8× 186 0.7× 203 0.8× 86 2.0k
Staffan Paulie Sweden 29 923 1.5× 298 0.5× 1.3k 2.9× 291 1.1× 66 0.3× 76 2.7k
Héctor Martínez-Valdez United States 23 747 1.2× 300 0.5× 1.1k 2.5× 223 0.9× 122 0.5× 48 2.2k
Nicole Schneiderhan‐Marra Germany 20 611 1.0× 207 0.4× 325 0.7× 206 0.8× 58 0.2× 65 1.5k
Amanda E. Starr Canada 20 1.4k 2.3× 681 1.2× 326 0.7× 55 0.2× 260 1.1× 27 2.6k

Countries citing papers authored by Steve Hobbs

Since Specialization
Citations

This map shows the geographic impact of Steve Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Hobbs more than expected).

Fields of papers citing papers by Steve Hobbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Hobbs. The network helps show where Steve Hobbs may publish in the future.

Co-authorship network of co-authors of Steve Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Hobbs. A scholar is included among the top collaborators of Steve Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Hobbs. Steve Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Paul A., Toby Roe, Steve Hobbs, et al.. (2019). Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer. Oncogene. 38(25). 5076–5090. 29 indexed citations
2.
Smith, Jeffrey R., Emmanuel de Billy, Steve Hobbs, et al.. (2013). Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins. Oncogene. 34(1). 15–26. 34 indexed citations
4.
Jones, Neil P., et al.. (2007). Phospholipase Cγ1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion. Oncogene. 27(20). 2823–2832. 13 indexed citations
5.
Poppe, Carine, et al.. (2006). Cognitive functioning and postconcussive symptoms in trauma patients with and without mild TBI. Archives of Clinical Neuropsychology. 21(4). 255–273. 127 indexed citations
6.
Lemmo, Anthony V., et al.. (2004). Micro Parallel Liquid Chromatography: Enabling Technology for Discovery Analytical Chemistry. Assay and Drug Development Technologies. 2(4). 389–396. 8 indexed citations
7.
Welsh, Sarah J., Steve Hobbs, & G. Wynne Aherne. (2003). Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition. European Journal of Cancer. 39(3). 378–387. 32 indexed citations
8.
Huang, Guofu, Steve Hobbs, Michael Walton, & Richard J. Epstein. (2002). Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells. British Journal of Cancer. 86(7). 1104–1109. 23 indexed citations
9.
Rogers, Paul, Philip Beale, Mansour Al‐Moundhri, et al.. (2001). Overexpression of BclXL in a human ovarian carcinoma cell line: Paradoxic effects on chemosensitivity in vitro versus in vivo. International Journal of Cancer. 97(6). 858–863. 10 indexed citations
10.
Sharp, Swee Y., Lloyd R. Kèlland, Melanie Valenti, et al.. (2000). Establishment of an Isogenic Human Colon Tumor Model forNQO1Gene Expression: Application to Investigate the Role of DT-Diaphorase in Bioreductive Drug Activation In Vitro and In Vivo. Molecular Pharmacology. 58(5). 1146–1155. 62 indexed citations
11.
Mehta, Lina K., et al.. (1999). Phthalimide analogs of CB 1954. Anti-Cancer Drugs. 10(8). 777–784. 6 indexed citations
12.
Hobbs, Steve, et al.. (1998). Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines. British Journal of Cancer. 78(2). 175–180. 37 indexed citations
13.
Cui, Wei, M. Rufus Crompton, Graham Harold, et al.. (1997). Selective cell ablation in transgenic mice expressing E. coli nitroreductase. Gene Therapy. 4(2). 101–110. 57 indexed citations
14.
Gyure, L A, Judith G. Hall, Steve Hobbs, & L. Elizabeth Jackson. (1991). IgA antibodies in the bile of rats. V. Primacy of the GALT as a source of IgA.. PubMed. 72(1). 85–8. 5 indexed citations
15.
Staines, Norman A., Theresa Ekong, Henry J. Thompson, et al.. (1990). Low affinity antibodies against collagen type II are associated with pathology in collagen-induced arthritis in mice. Journal of Autoimmunity. 3(6). 643–657. 11 indexed citations
16.
Peppard, Jane, Steve Hobbs, & L. Elizabeth Jackson. (1989). Role of carbohydrate in binding of IgG to the Fc receptor of neonatal rat enterocytes. Molecular Immunology. 26(5). 495–500. 5 indexed citations
17.
Poulter, L W, O Duke, G S Panayi, et al.. (1985). Activated T Lymphocytes of the Synovial Membrane in Rheumatoid Arthritis and Other Arthropathies. Scandinavian Journal of Immunology. 22(6). 683–690. 50 indexed citations
18.
Seymour, G. J., M Bofill, Steve Hobbs, et al.. (1983). The reactivity of a monoclonal antibody against cells of the monocyte-macrophage series in sections of normal and inflamed human tissues.. PubMed. 34(6). 463–73. 13 indexed citations
19.
Hobbs, Steve, et al.. (1983). Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.. PubMed. 50(4). 565–73. 1 indexed citations
20.
Selby, Warwick, L W Poulter, Steve Hobbs, D P Jewell, & George Janossy. (1983). Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.. Journal of Clinical Pathology. 36(4). 379–384. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026